Nephropathy Clinical Trials in Philadelphia, Pennsylvania
9 recruitingPhiladelphia, Pennsylvania
Showing 1–9 of 9 trials
Recruiting
Phase 2
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Primary Membranous Nephropathy
Climb Bio, Inc.45 enrolled45 locationsNCT07096843
Recruiting
Phase 3
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Primary Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals31 enrolled15 locationsNCT06994845
Recruiting
Not Applicable
NEPTUNE Match Study
Nephrotic Syndrome in ChildrenAlport SyndromeFocal Segmental Glomerulosclerosis+6 more
University of Michigan375 enrolled16 locationsNCT04571658
Recruiting
Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
Membranous NephropathyNephrotic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID)58 enrolled20 locationsNCT03949855
Recruiting
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Blood PressureNeuropathyDiabetes+6 more
Jaeb Center for Health Research200 enrolled18 locationsNCT06837181
Recruiting
Phase 4
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Calliditas Therapeutics AB60 enrolled38 locationsNCT06712407
Recruiting
Phase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Alport SyndromeFocal Segmental GlomerulosclerosisImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc.67 enrolled47 locationsNCT05003986
Recruiting
Not Applicable
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
SepsisSeptic ShockSepsis Mrsa+4 more
Children's Hospital of Philadelphia52,500 enrolled4 locationsNCT05975671
Recruiting
Nephrotic Syndrome Study Network
Membranous NephropathyGlomerulosclerosis, Focal SegmentalMinimal Change Disease (MCD)
University of Michigan1,200 enrolled44 locationsNCT01209000